Yusuf Kemal ARSLAN, Eren DÜZGÜN, Ceyda TANOĞLU, Dilek BADAY KESKİN

Validation and Cross-cultural Adaptation and Reliability ofthe Turkish Version of the Michigan Neuropathy ScreeningInstrument in the Eastern Anatolia Region of Turkey

Aim: Distal symmetric polyneuropathy is a common complication causing foot ulcers and amputations in diabetic patients. TheMichigan Neuropathy Screening Instrument (MNSI) is one of the screening methods of diabetic neuropathy, which also providesa comprehensive foot evaluation. The aim of this study was to evaluate the validation, cross-cultural adaptation, and reliability ofTurkish Version of the MNSI in the Eastern Anatolia region of Turkey.Materials and Methods: One hundred twenty-six patients with diabetes mellitus were randomly assigned to the study. Thequestionnaire section of the MNSI was completed by the patients, and the physical examination section was evaluated by healthprofessionals. Nerve conduction studies were performed to 123 patients as the gold standard for diabetic neuropathy. All nerveconduction studies and patients were evaluated by a neurologist.Results: The inter-rater agreement of questionnaire section [ICC: 0.957 (95% CI: 0.940-0.969), p

PDF

___

1. Saeedi P, Petersohn I, Salpea P, et al. Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: Results from the International Diabetes Federation Diabetes Atlas, 9th edition. Diabetes Res Clin Pract 2019;157:107843.
2. Satman I, Omer B, Tutuncu Y, Kalaca S, Gedik S, Dinccag N, et al. Twelve-year trends in the prevalence and risk factors of diabetes and prediabetes in Turkish adults. Eur J Epidemiol 2013;28:169-80.
3. Feldman EL, Callaghan BC, Pop-Busui R, et al. Diabetic neuropathy. Nat Rev Dis Prim 2019;5:41.
4. American Diabetes Association. 10. Microvascular Complications and Foot Care: Standards of Medical Care in Diabetes-2018. Diabetes Care. 2018;41:105- 18.
5. Wang F, Zhang J, Yu J, et al. Diagnostic Accuracy of Monofilament Tests for Detecting Diabetic Peripheral Neuropathy: A Systematic Review and Meta-Analysis. J Diabetes Res. 2017;2017:8787261.
6. Pourhamidi K, Dahlin LB, Englund E, Rolandsson O. Evaluation of clinical tools and their diagnostic use in distal symmetric polyneuropathy. Prim Care Diabetes 2014;8:77-84.
7. Barbosa M, Saavedra A, Severo M, et al. Validation and Reliability of the Portuguese Version of the Michigan Neuropathy Screening Instrument. Pain Pract 2017;17:514-21.
8. Fateh HR, Madani SP, Heshmat R, et al. Correlation of Michigan neuropathy screening instrument, United Kingdom screening test and electrodiagnosis for early detection of diabetic peripheral neuropathy. J Diabetes Metab Disord 2015;15:8.
9. Feldman EL, Stevens MJ, Thomas PK, et al. A practical two-step quantitative clinical and electrophysiological assessment for the diagnosis and staging of diabetic neuropathy. Diabetes Care 1994;17:1281-9.
10. Pop-Busui R, Lu J, Lopes N, et al. BARI 2D Investigators. Prevalence of diabetic peripheral neuropathy and relation to glycemic control therapies at baseline in the BARI 2D cohort. J Peripher Nerv Syst 2009;14:1- 13.
11. Terwee CB, Bot SDM, de Boer MR, et al. Quality criteria were proposed for measurement properties of health status questionnaires. J Clin Epidemiol 2007;60:34- 42.
12. Herman WH, Pop-Busui R, Braffett BH, et al. Use of the Michigan Neuropathy Screening Instrument as a measure of distal symmetrical peripheral neuropathy in Type 1 diabetes: results from the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications. Diabet Med 2012;29:937-44.
13. Wild D, Grove A, Martin M, et al. Principles of Good Practice for the Translation and Cultural Adaptation Process for Patient-Reported Outcomes (PRO) Measures: report of the ISPOR Task Force for Translation and Cultural Adaptation. Value Health 2005;8:94–104.
14. Bae JS, Kim BJ. Subclinical diabetic neuropathy with normal conventional electrophysiological study. J Neurol 2007;254:53-9.
15. Cicchetti DV. Guidelines, criteria, and rules of thumb for evaluating normed and standardized assessment instruments in psychology. Psychol Assess 1994;6:284-90.
16. Hooper D, Coughlan J, Mullen M. Structural Equation Modelling: Guidelines for Determining Model Fit. Electron J Bus Res Methods 2008;6:53-60.
17. Epskamp, S.,&Stuber S. semPlot: Path diagrams and visual analysis of various SEM packages’ output. R Packag version 2014;1.
18. Youden WJ. Index for rating diagnostic tests. Cancer. 1950;3:32-5.
19. Unal I. Defining an Optimal Cut-Point Value in ROC Analysis: An Alternative Approach. Comput Math Methods Med 2017;2017:1-14.
20. Aktar Reyhanioglu D, Adiyaman SC, Bektas M, et al. Turkish validity and reliability of the Michigan Neuropathy Screening Instrument. Turkish J Med Sci 2020.
21. Kaymaz S, Alkan H, Karasu U, et al. Turkish version of the Michigan Neuropathy Screening Instrument in the assessment of diabetic peripheral neuropathy: a validity and reliability study. Diabetol Int 2020;11:283- 92.
22. Barbosa M, Saavedra A, Severo M, et al. Validation and Reliability of the Portuguese Version of the Michigan Neuropathy Screening Instrument. Pain Pract. 2017;17:514-21.
23. de Macedo GMC, Nunes S, Barreto T. Skin disorders in diabetes mellitus: an epidemiology and physiopathology review. Diabetol Metab Syndr 2016;8:63.
24. Pavicic T, Korting HC. Xerosis and callus formation as a key to the diabetic foot syndrome: Dermatologic view of the problem and its management. JDDG 2006;4:935-41.
25. Kästenbauer T, Sauseng S, Brath H, et al. The value of the Rydel-Seiffer tuning fork as a predictor of diabetic polyneuropathy compared with a neurothesiometer. Diabet Med 2004;21:563-7.
26. Prabhakar AT, Suresh T, Kurian DS, et al. Timed Vibration Sense and Joint Position Sense Testing in the Diagnosis of Distal Sensory Polyneuropathy. J Neurosci Rural Pract 2019;10:273-7.
27. Gin H, Rigalleau V, Baillet L, et al. Comparison between monofilament, tuning fork and vibration perception tests for screening patients at risk of foot complication. Diabetes Metab 2002;28:457-61.
28. Perkins B, Bril V. Electrophysiologic testing in diabetic neuropathy. Handb Clin Neurol 2014;126:235-48.
29. Fillingim RB. Individual Differences in Pain: Understanding the Mosaic that Makes Pain Personalitle. Pain 2017;158:11-8.
30. Cheng CW, Wong CS, Hui GK, et al. Fibromyalgia : is it a neuropathic pain ? Pain Manag 2018;8:377-83.